Clinical trial
Effect of Early Correction of Anemia on the Progression of Chronic Renal Insufficiency (ECAP)
NCT00312871 is registered in ClinicalTrials.gov with Janssen Cilag S.A.S. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Early Correction of Anemia on the Progression of Chronic Renal Insufficiency (ECAP)
- Lead sponsor
- Janssen Cilag S.A.S.
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 28, 2001
- Completion date
- June 30, 2003
- Enrollment
- 217 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, renal failure, chronic renal failure